Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Type I interferon and cancer.
Holicek P, Guilbaud E, Klapp V, Truxova I, Spisek R, Galluzzi L, Fucikova J. Holicek P, et al. Immunol Rev. 2024 Jan;321(1):115-127. doi: 10.1111/imr.13272. Epub 2023 Sep 4. Immunol Rev. 2024. PMID: 37667466 Review.
Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.
Holicek P, Truxova I, Rakova J, Salek C, Hensler M, Kovar M, Reinis M, Mikyskova R, Pasulka J, Vosahlikova S, Remesova H, Valentova I, Lysak D, Holubova M, Kaspar P, Prochazka J, Kasikova L, Spisek R, Galluzzi L, Fucikova J. Holicek P, et al. Cell Death Dis. 2023 Mar 24;14(3):209. doi: 10.1038/s41419-023-05728-w. Cell Death Dis. 2023. PMID: 36964168 Free PMC article.
Peripheral gene signatures reveal distinct cancer patient immunotypes with therapeutic implications for autologous DC-based vaccines.
Hensler M, Rakova J, Kasikova L, Lanickova T, Pasulka J, Holicek P, Hraska M, Hrnciarova T, Kadlecova P, Schoenenberger A, Sochorova K, Rozkova D, Sojka L, Drozenova J, Laco J, Horvath R, Podrazil M, Hongyan G, Brtnicky T, Halaska MJ, Rob L, Ryska A, Coosemans A, Vergote I, Garg AD, Cibula D, Bartunkova J, Spisek R, Fucikova J. Hensler M, et al. Among authors: holicek p. Oncoimmunology. 2022 Jul 22;11(1):2101596. doi: 10.1080/2162402X.2022.2101596. eCollection 2022. Oncoimmunology. 2022. PMID: 35898703 Free PMC article.
Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents.
Fucikova J, Palova-Jelinkova L, Klapp V, Holicek P, Lanickova T, Kasikova L, Drozenova J, Cibula D, Álvarez-Abril B, García-Martínez E, Spisek R, Galluzzi L. Fucikova J, et al. Among authors: holicek p. Trends Cancer. 2022 May;8(5):426-444. doi: 10.1016/j.trecan.2022.01.010. Epub 2022 Feb 16. Trends Cancer. 2022. PMID: 35181272 Review.
Calreticulin exposure on malignant blasts correlates with improved natural killer cell-mediated cytotoxicity in acute myeloid leukemia patients.
Truxova I, Kasikova L, Salek C, Hensler M, Lysak D, Holicek P, Bilkova P, Holubova M, Chen X, Mikyskova R, Reinis M, Kovar M, Tomalova B, Kline JP, Galluzzi L, Spisek R, Fucikova J. Truxova I, et al. Among authors: holicek p. Haematologica. 2020 Jul;105(7):1868-1878. doi: 10.3324/haematol.2019.223933. Epub 2019 Oct 3. Haematologica. 2020. PMID: 31582537 Free PMC article.
Induction, regulation and roles of neural adhesion molecule L1CAM in cellular senescence.
Mrazkova B, Dzijak R, Imrichova T, Kyjacova L, Barath P, Dzubak P, Holub D, Hajduch M, Nahacka Z, Andera L, Holicek P, Vasicova P, Sapega O, Bartek J, Hodny Z. Mrazkova B, et al. Among authors: holicek p. Aging (Albany NY). 2018 Mar 28;10(3):434-462. doi: 10.18632/aging.101404. Aging (Albany NY). 2018. PMID: 29615539 Free PMC article.